CLINICAL PROGRAMS
Spravato is notable for being one of the first new approaches to treating depression in decades.
Spravato is the brand name for esketamine, a medication used for the treatment of major depressive disorder (MDD) and treatment-resistant depression.
About Spravato
SPRAVATO also known as Esketamine, is a medication that was approved by the U.S. Food and Drug Administration (FDA) in 2019 for the treatment of severe depression, specifically treatment resistant depression (TRD) or major depressive disorder (MDD) with acute suicidal ideation or behavior. It is specifically used for individuals who have not responded well to a variety of antidepressant treatments and alternative treatment options.
Spravato contains Esketamine, a derivative of Ketamine which is an anesthetic medication and is administered as a nasal spray.
Spravato is typically used in conjunction with an oral antidepressant and is administered under the supervision of a healthcare professional in a controlled healthcare setting.
Spravato contains Esketamine, a derivative of Ketamine which is an anesthetic medication and is administered as a nasal spray.
Spravato is typically used in conjunction with an oral antidepressant and is administered under the supervision of a healthcare professional in a controlled healthcare setting.
How do I know if Spravato is for me?
Qualifying for Spravato involves a thorough assessment by a healthcare provider to determine if the treatment is appropriate for your condition. Spravato is typically prescribed for individuals who have been diagnosed with treatment-resistant depression or major depressive disorder that has not responded adequately to other treatments.
Here are the General Steps that are often involved in qualifying for Spravato treatment:
- 1. Consultation: A consultation with one of our INBS psychiatric providers is necessary. A thorough medical history, treatment history, current symptoms, and any potential contraindications will be assessed during the consultation.
- 2. Diagnosis: One must have a formal diagnosis of treatment-resistant depression or major depressive disorder by a qualified mental health professional. This diagnosis is based on the presence of specific symptoms and criteria.
- 3. Previous treatment attempts: Qualification usually requires evidence of previous unsuccessful attempts with other antidepressant treatments. These could include multiple trials of different medications or various types of psychotherapy, or other treatment alternatives.
- 4. Medical Evaluation: A medical evaluation is conducted to ensure that you do not have any medical conditions or medications that might pose a risk or contraindication to Spravato treatment. Your overall health will be assessed to determine the appropriateness of the treatment.
- 5. Informed Consent: Before beginning Spravato treatment, you will be required to provide informed consent, which involves a clear understanding of the treatment, its potential benefits, risks, and side effects. This step ensures you are making an informed decision.
- 6. Insurance Coverage: insurance coverage for Spravato treatment varies depending on your specific insurance plan, location, and individual circumstances. Insurance plans often require prior authorization before they cover the cost of treatment. This process may take a few days to a few weeks, depending on the insurance company and medical necessity.
- 7. Treatment Plan: If you are deemed suitable for Spravato treatment, a personalized treatment plan will be developed. This plan includes the frequency and duration of treatment sessions, as well as any other complementary treatments that might be recommended. The minimum time requirement per FDA guidelines is 2 hours (120 minutes).
- 8. Monitoring and Assessment: Throughout the treatment course you will be closely monitored by your healthcare team. This monitoring helps assess your response to the treatment, any potential side effects, and the overall progress of your mental health. This process includes routine vital signs and room camera monitoring for the duration of each treatment.
WHAT TO EXPECT DURING YOUR SPRAVATO TREATMENT:
- 1. Initial Assessment: This process begins with a comprehensive evaluation by a healthcare professional and includes routine vital signs. This assessment aims to determine your suitability for treatment.
- 2. Administration: Spravato is administered as a nasal spray under the supervision of a healthcare provider. You will receive each dose in a controlled setting at a certified treatment center. This ensures safety and allows of immediate monitoring of your response.
- 3. Observation Period: After receiving the nasal spray, you will be closely monitored for a designated period to ensure you don’t experience any adverse reactions. Healthcare professionals are present to provide assistance if needed. Our treatment rooms are equipped with cameras to ensure your safety throughout the duration of the each treatment.
- 4. Treatment Sessions: Your treatment plan may involve multiple sessions over several weeks. These sessions are spaced out according to the protocol and guidelines, and progress is continually assessed by your healthcare team.
- 5. Response Monitoring: Throughout your treatment, your mental health progress will be monitored and evaluated. Your healthcare provider will engage with you in discussions to evaluate the impact of the treatment on your symptoms and well-being.
- 6. Adjustments: Depending on your response, your treatment plan might be adjusted to optimize its effectiveness. This could involve changes in dosage or frequency to better suit your individual needs.
- 7. Collaboration: Your healthcare team will collaborate closely with you to ensure that your treatment aligns with your goals and preferences. Open communication is encouraged to address any concerns or questions you may have.
- 8. Continued Care: After initial treatment period, your healthcare provider will work with you to create a plan for ongoing mental health management. This might include a combination of treatments, therapy, and lifestyle adjustments.
Commonly reported side effects of Spravato treatment:
Dissociation: feelings of detachment from oneself or the environment. This can lead to changes in perception, feeling “out of body,” or experiencing dream-like state.
Dizziness or Vertigo: may experience dizziness, spinning sensations, or vertigo during or after treatment sessions.
Nausea: feeling of queasiness can occur following treatment.
Increased Blood Pressure: Some people may experience an increase in blood pressure after Spravato administration. Blood pressure should be monitored before and after each treatment sessions.
Sedation or Sleepiness: feeling drowsy or experiencing sedation is possible during and after each treatment.
Feeling “Drunk”: Some individuals might describe feeling “drunk” or having altered coordination and cognitive function after treatment.
Headache: Headaches are a relatively common side effect of Spravato treatment.
Vomiting: In some cases, vomiting can occur as a side effect.
Disorientation: feeling confused or disoriented may occur after treatment sessions.
Anxiety or Restlessness: Some individuals may experience increased anxiety or restlessness.
Lightheadedness: a sensation of feeling faint can occur.
It is important to note that not everyone will experience these side effects, and severity and frequency can vary from person to person.
It is important that individuals are monitored and closely observed during and after each treatment sessions to ensure safety.
Dizziness or Vertigo: may experience dizziness, spinning sensations, or vertigo during or after treatment sessions.
Nausea: feeling of queasiness can occur following treatment.
Increased Blood Pressure: Some people may experience an increase in blood pressure after Spravato administration. Blood pressure should be monitored before and after each treatment sessions.
Sedation or Sleepiness: feeling drowsy or experiencing sedation is possible during and after each treatment.
Feeling “Drunk”: Some individuals might describe feeling “drunk” or having altered coordination and cognitive function after treatment.
Headache: Headaches are a relatively common side effect of Spravato treatment.
Vomiting: In some cases, vomiting can occur as a side effect.
Disorientation: feeling confused or disoriented may occur after treatment sessions.
Anxiety or Restlessness: Some individuals may experience increased anxiety or restlessness.
Lightheadedness: a sensation of feeling faint can occur.
It is important to note that not everyone will experience these side effects, and severity and frequency can vary from person to person.
It is important that individuals are monitored and closely observed during and after each treatment sessions to ensure safety.
Spravato® Treatment Center
SPRAVATO® PATIENT VIDEO: NICOLE’S STORY
The Institute is a multidisciplinary group of board certified mental health specialists servicing Southwestern Chicago and the neighboring suburbs in general psychiatry and selected psychiatric sub-specialties using state of the art techniques.
An innovative program that combines clinical, educational, training, research, and community-oriented components, the Institute covers general psychiatry with several specialized programs.
An innovative program that combines clinical, educational, training, research, and community-oriented components, the Institute covers general psychiatry with several specialized programs.
SPRAVATO® PATIENT VIDEO: WHAT TO EXPECT DURING YOUR SPRAVATO® TREATMENT
The Institute is a multidisciplinary group of board certified mental health specialists servicing Southwestern Chicago and the neighboring suburbs in general psychiatry and selected psychiatric sub-specialties using state of the art techniques.
An innovative program that combines clinical, educational, training, research, and community-oriented components, the Institute covers general psychiatry with several specialized programs.
An innovative program that combines clinical, educational, training, research, and community-oriented components, the Institute covers general psychiatry with several specialized programs.
